Range Low Price High Price Comment
30 days $38.96 $53.18 Wednesday, 27th Mar 2024 CLDX stock ended at $41.79. This is 1.83% more than the trading day before Tuesday, 26th Mar 2024. During the day the stock fluctuated 4.18% from a day low at $40.66 to a day high of $42.36.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
2024-01-16 $41.65 $43.05 $40.65 $41.59 1 386 794
2024-01-12 $41.63 $42.18 $40.01 $42.04 1 422 268
2024-01-11 $38.05 $41.57 $37.78 $41.03 1 070 400
2024-01-10 $40.14 $40.81 $37.87 $38.49 526 893
2024-01-09 $40.87 $41.13 $40.10 $40.30 536 804
2024-01-08 $39.00 $41.63 $38.60 $41.59 534 473
2024-01-05 $38.68 $39.72 $37.96 $39.68 421 508
2024-01-04 $39.52 $40.40 $38.84 $39.11 316 802
2024-01-03 $40.02 $40.28 $38.85 $39.36 412 785
2024-01-02 $39.28 $40.99 $39.20 $40.41 448 420
2023-12-29 $39.98 $40.24 $38.55 $39.66 555 943
2023-12-28 $40.70 $41.47 $39.92 $40.00 527 571
2023-12-27 $40.29 $40.90 $39.67 $40.65 458 037
2023-12-26 $39.48 $40.63 $39.47 $40.22 434 544
2023-12-22 $38.19 $39.72 $38.19 $39.48 458 705
2023-12-21 $38.33 $38.50 $37.47 $37.81 299 911
2023-12-20 $38.52 $39.18 $37.55 $37.78 648 905
2023-12-19 $37.24 $38.37 $36.73 $37.92 649 725
2023-12-18 $37.35 $37.43 $36.14 $36.85 484 390
2023-12-15 $36.43 $37.49 $36.36 $37.15 811 980
2023-12-14 $35.86 $36.41 $34.85 $36.15 809 750
2023-12-13 $32.06 $34.88 $31.87 $34.68 955 217
2023-12-12 $31.10 $32.06 $30.56 $32.06 369 670
2023-12-11 $31.31 $31.39 $30.66 $31.11 291 386
2023-12-08 $31.87 $32.66 $31.30 $31.43 334 821
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT